Clinical Trial Update: Comparison of Topical 0.15% Gancyclovir Gel Versus 0.3% Hypromellose Gel for the Treatment of Herpes Zoster Keratitis [Phase 2]

View source ↗

Summary

Phase 2 trial comparing topical ganciclovir gel to hypromellose gel for herpes zoster keratitis was terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Herpes Zoster Keratitis

Drugs mentioned

• Ganciclovir 0.15% gel (ganciclovir)
• Hypromellose gel 0.3% (hypromellose)

Snippet

Sponsor: Northwestern University | Conditions: Herpes Zoster Keratitis | Phase 2 | Status: TERMINATED | Results posted: 2021-07-08